What is Meridian Bioscience?
Meridian Bioscience operates as a fully integrated life science enterprise, specializing in the development, manufacturing, and distribution of high-precision diagnostic tools and raw materials. By providing essential components for immunological and molecular testing, the company supports a diverse array of applications spanning human, animal, and environmental health. With a footprint extending across more than 70 countries, Meridian Bioscience leverages its Cincinnati-based headquarters to drive innovation in gastrointestinal, respiratory, and tropical disease diagnostics, positioning itself as a pivotal player in the global healthcare supply chain.
How much funding has Meridian Bioscience raised?
Meridian Bioscience has raised a total of $525M across 2 funding rounds:
Other Financing Round
$25M
Debt
$500M
Other Financing Round (2022): $25M, investors not publicly disclosed
Debt (2023): $500M led by J.P. Morgan Asset Management, Kookmin Bank, PNC Financial Services Group Inc, Standard Chartered, Standard Chartered Bank Ghana, Industrial Bank of Korea, Citi, and Export-Import Bank of Korea
Key Investors in Meridian Bioscience
J.P. Morgan Asset Management
A global financial services firm specializing in comprehensive investment management and wealth advisory services for institutional and individual clients.
Kookmin Bank
A prominent South Korean banking institution providing a wide range of financial services and capital solutions to support corporate growth.
PNC Financial Services Group Inc
A diversified financial services company in the United States offering extensive corporate and institutional banking, asset management, and credit solutions.
What's next for Meridian Bioscience?
Looking ahead, the recent influx of capital is expected to accelerate Meridian Bioscience's research and development initiatives, particularly in the refinement of its immunoassay and molecular diagnostic systems. By prioritizing speed, accuracy, and simplicity, the company is well-positioned to capture additional market share in the competitive life science sector. Strategic focus will likely remain on optimizing operational efficiencies and expanding its global distribution network to meet the rising demand for rapid, reliable diagnostic solutions in both clinical and research settings.
See full Meridian Bioscience company page
